Cyclooxygenase-2 in tumorigenesis of gastrointestinal cancers: An update on the molecular mechanisms
- 1 September 2010
- journal article
- review article
- Published by Elsevier BV in Cancer Letters
- Vol. 295 (1), 7-16
- https://doi.org/10.1016/j.canlet.2010.03.015
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statementThe Lancet Oncology, 2009
- Association of Nonsteroidal Anti-Inflammatory Drugs with Lung Cancer: Results from a Large Cohort StudyCancer Epidemiology, Biomarkers & Prevention, 2009
- Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysisBritish Journal of Cancer, 2009
- Breast Cancer and Use of Nonsteroidal Anti-inflammatory Drugs: A Meta-analysisJNCI Journal of the National Cancer Institute, 2008
- Aspirin and the Risk of Colorectal Cancer in Relation to the Expression of COX-2New England Journal of Medicine, 2007
- Celecoxib for the Prevention of Sporadic Colorectal AdenomasNew England Journal of Medicine, 2006
- A Large Cohort Study of Aspirin and Other Nonsteroidal Anti-inflammatory Drugs and Prostate Cancer IncidenceJNCI Journal of the National Cancer Institute, 2005
- The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous PolyposisNew England Journal of Medicine, 2000
- Rectal proliferation and polyp occurrence in patients with familial adenomatous polyposis after sulindac treatmentGastroenterology, 1994
- Treatment of Colonic and Rectal Adenomas with Sulindac in Familial Adenomatous PolyposisNew England Journal of Medicine, 1993